Combined COVID-19 and quadrivalent seasonal influenza vaccine (Medigen Vaccine Biologics/Vaxess Technologiess)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameCombined COVID-19 and quadrivalent seasonal influenza vaccine (Medigen Vaccine Biologics/Vaxess Technologiess)
Drug Alias NameCOVID-2019-quadrivalent seasonal influenza combined vaccine (Medigen Vaccine Biologics/Vaxess Technologies)
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Vaccine type > Combination vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Influenza, Human
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMedigen Vaccine Biologics CorpVaxess Technologies Inc
China Registration ClassN/A

Develop Information

Active CompaniesMedigen Vaccine Biologics Corp
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)Influenza, Human
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A